We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Joey V. Quitania
Joey V. Quitania
Products
PRODUCTS
Pharmalogic Los Angeles, LLC
Joey V. Quitania
Price:
$117.00
View
International Medication Systems Ltd.
Joey V. Quitania
,
Lisa Shin
, and
Khoa Nathan V. Tran
Price:
$117.00
View
Nitto Avecia Pharma Services, Inc.
Lixia Cai
,
Eileen A. Liu
,
Anita Narula
, and
Joey V. Quitania
Price:
$117.00
View
Stason Pharmaceuticals, Inc.
Walden H. Lee
and
Joey V. Quitania
Price:
$117.00
View
Respironics California, Inc.
Virgilio F. Facio
,
Shaquenta Y. Perkins
, and
Joey V. Quitania
Price:
$117.00
View
Ajinomoto Althea, Inc.
Joey V. Quitania
Price:
$117.00
View
Zions Rx Formulations Services, LLC
Paul Bonneau
and
Joey V. Quitania
Price:
$117.00
View
Civic Center Pharmacy
Joey V. Quitania
Price:
$117.00
View
TME Enterprises dba U.S. Apothecary Laboratory
Arsen Karapetyan
,
Joey V. Quitania
, and
Sundy Ven
Price:
$117.00
View
Teva Parenteral Medicines, Inc.
Kim Thomas Cruse
,
Virgilio F. Facio
,
Jennifer M. Gogley
,
Carla J. Lundi
,
Joey V. Quitania
, and
Comyar Shoghi
Price:
$117.00
View
View All Products by Joey V. Quitania
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
From QSR to QMSR: Meeting FDA’s New Requirements
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
